The prognosis of colorectal cancer patients after indocyanine green fluorescence-guided radical surgery: a prospective randomized controlled trial

Evaluation of the prognosis of colorectal cancer patients after indocyanine green fluorescence-guided radical surgery: a randomized controlled trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100043817

Enrollment

Unknown

Registered

2021-03-04

Start date

2021-03-08

Completion date

Unknown

Last updated

2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

ICG-guided:ICG-guided surgery

control group:routine surgery

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adults over 18 years old; 2. Patients with colorectal cancer confirmed by pathology before operation; 3. Patients who plan to undergo laparoscopic radical resection of colorectal cancer.

Exclusion criteria

Exclusion criteria: 1. Those patients with colorectal cancer with distant metastasis have been identified; 2. Patients with coagulation dysfunction; 3. Pregnant or pregnant subjects; 3. Patients with multiple organ tumors or severe uncontrolled medical diseases or acute infection at the same time; 4. According to the judgment of the researcher, it may interfere with the test results or increase the risk of patients.

Design outcomes

Primary

Measure	Time frame
disease free survival;overal survival;	—

Secondary

Measure	Time frame
number of lymph node;	—

Countries

China

Contacts

Public ContactSun Peng

Tongren Hospital Affiliated to Medical College of Shanghai Jiaotong University

SP2082@shtrhospital.com18121225835

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026